DURHAM, N.C.--(BUSINESS WIRE)--Argos Therapeutics today announced the presentation of an abstract related to its Arcelis™ HIV immunotherapy program at the Keystone Symposia Global Health Series conference on HIV Immunobiology, held March 22 - 27 in Keystone, CO. The poster presentation details important research on the immunosuppressive properties of HIV, and how this research may influence the development of HIV immunotherapies.
